ALEF.V - Aleafia Health Inc.

TSXV - TSXV Delayed Price. Currency in CAD
2.3600
+0.0500 (+2.16%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close2.3100
Open2.3400
Bid2.36 x 0
Ask2.37 x 0
Day's Range2.2900 - 2.4300
52 Week Range0.4700 - 4.7000
Volume1,558,031
Avg. Volume1,413,538
Market Cap373.51M
Beta (3Y Monthly)4.61
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.50
  • Aleafia Health Announces new President of Clinic Operations
    GlobeNewswire18 hours ago

    Aleafia Health Announces new President of Clinic Operations

    White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem AcquisitionPreviously the COO of Canada’s Largest Multidisciplinary Clinic Network.

  • GlobeNewswire9 days ago

    Aleafia Health Helps Patients & Investors with Revenue Generating Research -- CFN Media

    SEATTLE, Wash., Feb. 07, 2019 (GLOBE NEWSWIRE) -- -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article featuring Aleafia Health Inc. (ALEF.V) (ALEAF) (ARAH.F). The company is well-equipped to study the effects of cannabis with its wholly-owned network of more than 20 Canabo Medical Clinics with over 50,000 patients. Aleafia Health’s research division generated $612,000 in revenue in Q3 2018, and the Company is building on that success.

  • Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow
    GlobeNewswire12 days ago

    Aleafia Health to Accelerate Research Division with Appointment of Product Data Science Fellow

    Research Revenue Totalled $0.6 Million in Q3 2018Product Data Science Fellow to Lead Evidence-Based Product Research via Proprietary, 10M Point Patient Dataset TORONTO, Feb..

  • ACCESSWIRE21 days ago

    4 Marijuana Stocks Making Moves on Friday (1/25/19)

    With so many legal initiatives occurring throughout the industry in North America and beyond, the cannabis industry has garnered copious amounts of public approval, resulting in the increase in investor excitement emanating from those looking for promising opportunities. Some studies have shown that the global cannabis industry is worth as much as $50 billion, which, if conditions remain the same, will only grow over time. The Green Organic Dutchman Holdings Ltd (TGOD.TO) (TGODF), Aleafia Health Inc (ALEAF) (ALEF.V), Innovative Industrial Properties Inc (IIPR), and Pyxus International Inc (PYX) represent 4 pot stocks worth keeping tabs on as we close out this week.

  • Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment
    GlobeNewswire22 days ago

    Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”), announces today what it believes to be the first study reporting reduced benzodiazepine use among patients initiated and monitored on medical cannabis. The retrospective study, published in Cannabis and Cannabinoid Research, a peer-reviewed journal, is entitled “Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis.” It found that 45.2 per cent of patients regularly consuming benzodiazepines had stopped taking the medication within approximately six months of beginning medical cannabis.

  • Baystreet22 days ago

    Stocks in play: Aleafia Health Inc.

    Announced today what it believes to be the first study reporting reduced benzodiazepine use among patients ...

  • GlobeNewswire25 days ago

    CFN Media's Exclusive Interview with Aleafia Health CEO Geoffrey Benic Discussing Emblem Corp. Acquisition

    SEATTLE, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article featuring Aleafia Health Inc’s. (ALEF.V) (ALEAF) (ARAH.F) CEO Geoffrey Benic discussing the company’s acquisition of Emblem Corp. creating Canada’s largest cannabis clinic network along with 138,000 kilograms per year of planned annual cultivation capacity—making it an overnight leader in the medical side of the nascent cannabis industry. CFN Media: Why did you initially decide to focus on medical clinics?

  • Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
    GlobeNewswire29 days ago

    Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited

    Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia Health”) or the (“Company”) is announcing its global expansion with the closing of its previously announced investment in CannaPacific Pty Limited (“CannaPacific”), a federally licensed Australian medical cannabis company located in New South Wales, Australia. CannaPacific is licensed by the Office of Drug Control (ODC) of Australia to cultivate medical cannabis (License MC020/18) and to research medical cannabis (License RL 012/18).

  • GlobeNewswirelast month

    Aleafia Fulfills First Transaction Under Cannabis Supply Agreement with CannTrust

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has sold two cannabis crops to CannTrust Holdings Inc. (TRST.TO)(“CannTrust”), together (the “Parties”), representing the first transactions under the Parties’ previously announced 15,000 kg cannabis supply agreement for 2019. The two crops purchased by CannTrust were harvested at Aleafia’s indoor Port Perry cultivation facility. “CannTrust continues to grow its medical patient base and is experiencing high demand for its recreational brands,” said CannTrust CEO Peter Aceto.

  • GlobeNewswirelast month

    Aleafia Has Buyers Lined Up as Greenhouse Goes into Production -- CFN Media

    SEATTLE, Jan. 10, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Aleafia Health Inc. (ALEF.V) (ALEAF) (FRA:ARAH) and its new greenhouse that’s moving into production later this year, along with its existing distribution channels that set it up for success—including a base of over 50,000 medical cannabis patients. Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. With more than a hundred licensed producers in the market, investors have shifted their focus from raw production capacity to durable competitive advantages.

  • GlobeNewswirelast month

    Aleafia Completes Phase One Construction and Retrofitting of Niagara Greenhouse Facility

    Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has completed Phase I construction and retrofitting of its Niagara Greenhouse facility (“Niagara”) located in Grimsby, Ontario. The Company expects to complete Phase II of the construction and retrofitting on the balance of the facility in late Q1 or early Q2 2019. The Company has also submitted the facility’s Evidence Package to Health Canada, marking the final stage in the Cultivation Licence application process.

  • GlobeNewswire2 months ago

    Aleafia-Emblem Merger Creates Canada’s Largest Network of Clinics -- CFN Media

    SEATTLE, Dec. 21, 2018 -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry,.

  • Baystreet2 months ago

    Stocks in play: Emblem Corp.

    And Aleafia Health Inc. have entered into a definitive agreement under which Aleafia will acquire, by ...

  • GlobeNewswire2 months ago

    Aleafia Health Inc. to Acquire Emblem Corp. to Create New Medical Cannabis Leader

    Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s.

  • GlobeNewswire2 months ago

    Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production -- CFN Media

    SEATTLE, Dec. 13, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing Aleafia Health Inc. (ALEF.V) (ALEAF) (FRA:ARAH). The company has taken a very strategic approach to the market. Management has also invested in global opportunities to help diversify revenue outside of Canada, while strategically growing into the recreational space.

  • GlobeNewswire2 months ago

    Aleafia Announces Results of Special Shareholders Meeting

    OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), is announcing the results of today’s Special Meeting of Shareholders (“The Meeting”). At the Meeting, Shareholders approved the ordinary resolution to permit certain amendments to the Company’s stock option plan (“Option Resolution”). Shareholders also endorsed an ordinary resolution to allow certain amendments to the Company’s restricted share unit plan (“Share Resolution”).

  • GlobeNewswire3 months ago

    Aleafia Posts Record Revenue in Q3 2018, 36% Increase Over Previous Quarter

    Recorded the first cannabis revenue in the company’s history, days after securing its Health Canada Sales Licence. Ft. Niagara Greenhouse is underway. Signed supply agreement with CannTrust, with Aleafia providing up to 15,000 kg of dried cannabis flower in 2019.

  • GlobeNewswire3 months ago

    Aleafia Closes Transactions with Serruya Private Equity

    OTCQX: ALEAF, FRA: ARAH) (“Aleafia“ or the “Company“) is pleased to announce that the previously announced joint venture and financing transactions with Serruya Private Equity (“Serruya”) have closed. “We look forward to immediately executing on our shared vision of building and scaling a retail cannabis network with immediate national reach and global expansion plans,” said Aaron Serruya, a principal of SPE. With final approvals now in place, we have delivered on that commitment,” said Aleafia CEO Geoffrey Benic.

  • GlobeNewswire3 months ago

    Aleafia to Release Q3 Results on November 26

    TORONTO, Nov. 23, 2018 -- Aleafia Health Inc. (TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH) (“Aleafia“) or (the “Company“), a highly differentiated cannabis company with major cannabis.

  • GlobeNewswire3 months ago

    Aleafia and Serruya Private Equity Reach Agreement for National Retail Dispensary, top Performing Brands and $10M Investment

    OTCQX: ALEAF, FRA: ARAH) (“Aleafia“ or the “Company“), and Serruya Private Equity (“Serruya” and together with the Company, the “Parties”), have settled final forms of definitive joint venture and other agreements that will see the Parties launch a Canada-wide cannabis retail Joint Venture (“Retail JV”) along with a domestic and international cannabis brands Joint-Venture (“Brands JV”, and together with the Retail JV, the “Joint Venture”). Serruya will also make a $10 million strategic investment in Aleafia via a non-brokered private placement financing (“Private Placement”) and Aleafia will invest $5 million of such gross proceeds of the Private Placement into the Joint Venture.